Skip to main content
Log in

Establishing the Framework for Tissue Engineered Heart Pumps

  • Published:
Cardiovascular Engineering and Technology Aims and scope Submit manuscript

Abstract

Development of a natural alternative to cardiac assist devices (CADs) will pave the way to a heart failure therapy which overcomes the disadvantages of current mechanical devices. This work provides the framework for fabrication of a tissue engineered heart pump (TEHP). Artificial heart muscle (AHM) was first fabricated by culturing 4 million rat neonatal cardiac cells on the surface of a fibrin gel. To form a TEHP, AHM was wrapped around an acellular goat carotid artery (GCA) and a chitosan hollow cylinder (CHC) scaffold with either the cardiac cells directly contacting the construct periphery or separated by the fibrin gel. Histology revealed the presence of cardiac cell layer cohesion and adhesion to the fibrin gel scaffold, acellular GCA, and synthesized CHC. Expression of myocytes markers, connexin43 and α-actinin, was also noted. Biopotential measurements revealed the presence of ~2.5 Hz rhythmic propagation of action potential throughout the TEHP. Degradation of the fibrin gel scaffold of the AHM via endogenous proteases may be used as a means of delivering the cardiac cells to cylindrical scaffolds. Further development of the TEHP model by use of multi-stimulus bioreactors may lead to the application of bioengineered CADs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Ahmed, T. A. E., E. V. Dare, and M. Hincke. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng. Part B. Rev. 14:199–215, 2008.

    Article  Google Scholar 

  2. Anversa, P., J. Kajstura, M. Rota, and A. Leri. Regenerating new heart with stem cells. J. Clin. Invest. 123:62–70, 2013.

    Article  Google Scholar 

  3. Barsotti, M. C., F. Felice, A. Balbarini, and R. Di Stefano. Fibrin as a scaffold for cardiac tissue engineering. Biotechnol. Appl. Biochem. 58:301–310, 2011.

    Article  Google Scholar 

  4. Birla, R. K., D. E. Dow, Y.-C. Huang, F. Migneco, L. Khait, G. H. Borschel, et al. Methodology for the formation of functional, cell-based cardiac pressure generation constructs in vitro. In Vitro Cell. Dev. Biol. Anim. 44:340–350, 2008.

    Article  Google Scholar 

  5. Camelliti, P., T. K. Borg, and P. Kohl. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 65:40–51, 2005.

    Article  Google Scholar 

  6. Cereghetti, C., C. Kaiser, and S. Cook. Ventricular assist devices in acute heart failure. Minerva Cardioangiol. 60:395–403, 2012.

    Google Scholar 

  7. Cohn, L. H. The role of mechanical devices. J. Card. Surg. 5:278–281, 1990.

    Article  Google Scholar 

  8. Engin, C., F. Ayik, E. Oguz, B. Eygi, T. Yagdi, S. Karakula, et al. Ventricular assist device as a bridge to heart transplantation in adults. Transplant. Proc. 43:927–930, 2011.

    Article  Google Scholar 

  9. Frazier, O. H. New technologies in the treatment of severe cardiac failure: the Texas Heart Institute experience. Ann. Thorac. Surg. 59:S31–S37, 1995; ((Discussion S38)).

    Article  Google Scholar 

  10. Fujimoto, K. L., K. C. Clause, L. J. Liu, J. P. Tinney, S. Verma, W. R. Wagner, et al. Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function. Tissue Eng. Part A 17:585–596, 2011.

    Article  Google Scholar 

  11. Gandaglia, A., R. Huerta-Cantillo, M. Comisso, R. Danesin, F. Ghezzo, F. Naso, et al. Cardiomyocytes in vitro adhesion is actively influenced by biomimetic synthetic peptides for cardiac tissue engineering. Tissue Eng. Part A 18:725–736, 2012.

    Article  Google Scholar 

  12. Gilbert, T. W., T. L. Sellaro, and S. F. Badylak. Decellularization of tissues and organs. Biomaterials 27:3675–3683, 2006.

    Google Scholar 

  13. Hecker, L., L. Khait, D. Radnoti, and R. Birla. Novel bench-top perfusion system improves functional performance of bioengineered heart muscle. J. Biosci. Bioeng. 107:183–190, 2009.

    Article  Google Scholar 

  14. Huang, Y.-C., L. Khait, and R. K. Birla. Contractile three-dimensional bioengineered heart muscle for myocardial regeneration. J. Biomed. Mater. Res. A. 80:719–731, 2007.

    Article  Google Scholar 

  15. Khait, L., and R. K. Birla. Cell-based cardiac pumps and tissue-engineered ventricles. Regen. Med. 2:391–406, 2007.

    Article  Google Scholar 

  16. Kubo, H., T. Shimizu, M. Yamato, T. Fujimoto, and T. Okano. Creation of myocardial tubes using cardiomyocyte sheets and an in vitro cell sheet-wrapping device. Biomaterials 28:3508–3516, 2007.

    Article  Google Scholar 

  17. Kupcsik, L., M. Alini, and M. J. Stoddart. Epsilon-aminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering. Tissue Eng. Part A 15:2309–2313, 2009.

    Article  Google Scholar 

  18. Melchiorri, A. J., N. Hibino, and J. P. Fisher. Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts. Tissue Eng. Part B. Rev. 19:292–307, 2013.

    Article  Google Scholar 

  19. Tao, Z.-W., M. Mohamed, M. Hogan, L. Gutierrez, and R. K. Birla. Optimizing a spontaneously contracting heart tissue patch with rat neonatal cardiac cells on fibrin gel. J. Tissue Eng. Regen. Med. 2014. doi:10.1002/term.1895.

  20. Villalona, G. A., B. Udelsman, D. R. Duncan, E. McGillicuddy, R. F. Sawh-Martinez, N. Hibino, et al. Cell-seeding techniques in vascular tissue engineering. Tissue Eng. Part B. Rev. 16:341–350, 2010.

    Article  Google Scholar 

Download references

Acknowledgments

The researchers would like to acknowledge NIH for provision of funding for this research. We would also like to thank the Department of Biomedical Engineering and the Cullen College of Engineering at University of Houston for further financial support.

Conflict of interest

Research was funded by NIH (Grant number: R01-EB011516).

Statement of Human Studies

No human studies were carried out by the authors for this article.

Statement of Animal Studies

Approval for animal use was granted by the Institutional Animal Care and Use Committee (IACUC) at the University of Houston, in accordance with the “Guide for the Care and Use of Laboratory Animals” (NIH publication 86-23, 1996).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ravi K. Birla.

Additional information

Associate Editor Ajit P. Yoganathan oversaw the review of this article.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (AVI 1090 kb)

Supplementary material 2 (AVI 781 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohamed, M.A., Hogan, M.K., Patel, N.M. et al. Establishing the Framework for Tissue Engineered Heart Pumps. Cardiovasc Eng Tech 6, 220–229 (2015). https://doi.org/10.1007/s13239-015-0211-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13239-015-0211-4

Keywords

Navigation